Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 13, 2019
Total Value: $1.067B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 2,060,135 | $237M | 22.2% | $26.35 | — | ADR | 04351P101 |
| CRNX | Crinetics Pharmaceuticals Inc | 3,375,169 | $84.38M | 7.9% | $29.69 | -16.6% | Common | 22663K107 |
| ARWR | Arrowhead Pharmaceuticals Inc | 2,765,153 | $73.28M | 6.9% | $10.24 | +114.3% | Common | 04280A100 |
| — | Tricida, Inc. | 1,424,525 | $56.21M | 5.3% | $34.22 | — | Common | 89610F101 |
| CDXS | Codexis, Inc | 2,614,458 | $48.18M | 4.5% | $3.85 | +400.2% | Common | 192005106 |
| INSM | Insmed Inc | 1,748,174 | $44.75M | 4.2% | $26.56 | +4.9% | Common Par | 457669307 |
| IOVA | Iovance Biotherapeutics, Inc. | 1,600,000 | $39.23M | 3.7% | $9.64 | +56.2% | Common | 462260100 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 3.6% | $7.22 | -10.3% | SHS | P8696W104 |
| — | Zymeworks Inc | 1,453,467 | $31.98M | 3.0% | $18.92 | — | Common | 98985W102 |
| KALV | KalVista Pharmaceuticals Inc. | 1,359,149 | $30.11M | 2.8% | $12.10 | +93.7% | Common | 483497103 |
| — | Kadmon Holdings Inc | 12,606,605 | $25.97M | 2.4% | $5.06 | — | Common | 48283N106 |
| — | The Medicines Company | 669,012 | $24.4M | 2.3% | $36.47 | — | Common | 584688105 |
| — | Menlo Therapeutics Inc. | 4,011,236 | $24.03M | 2.3% | $37.58 | — | Common | 586858102 |
| — | Mirati Therapeutics Inc. | 233,045 | $24M | 2.2% | $42.42 | — | Common | 60468T105 |
| — | Amyris, Inc | 6,490,557 | $23.11M | 2.2% | $5.26 | — | Common | 03236M200 |
| — | Homology Medicines, Inc. | 1,159,742 | $22.7M | 2.1% | $19.00 | — | Common | 438083107 |
| — | Eiger BioPharmaceuticals Inc | 1,791,257 | $18.99M | 1.8% | $16.42 | — | Common | 28249U105 |
| — | Orchard Therapeutics plc | 1,312,084 | $18.36M | 1.7% | $14.63 | — | ADS | 68570P101 |
| — | Chiasma Inc | 2,377,213 | $17.76M | 1.7% | $7.47 | — | Common | 16706W102 |
| — | Cymabay Therapeutics Inc | 2,154,934 | $15.43M | 1.4% | $12.90 | — | Common | 23257D103 |
| — | MEI Pharma Inc | 5,681,397 | $14.2M | 1.3% | $3.94 | — | Common | 55279B202 |
| XENE | Xenon Pharmaceuticals Inc | 1,405,476 | $13.86M | 1.3% | $11.59 | -17.4% | Common | 98420N105 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,913,623 | $12.59M | 1.2% | $5.89 | +8.1% | Common | 05156V102 |
| — | Soleno Therapeutics, Inc. | 4,268,959 | $11.95M | 1.1% | $1.84 | — | Common | 834203200 |
| RCKT | Rocket Pharmaceuticals Inc | 786,712 | $11.8M | 1.1% | $17.45 | 0.0% | Common | 77313F106 |
| — | Kiniksa Pharmaceuticals | 843,478 | $11.42M | 1.1% | $18.60 | — | Common | G5269C101 |
| — | Obseva SA | 937,147 | $10.6M | 1.0% | $15.18 | — | Common | H5861P103 |
| — | Nabriva Therapeutics AG | 4,039,139 | $9.815M | 0.9% | $6.08 | — | SHS | G63637105 |
| APLS | Apellis Pharmaceuticals, Inc. | 383,538 | $9.719M | 0.9% | $14.72 | +38.2% | Common | 03753U106 |
| — | Verona Pharma PLC | 1,492,951 | $7.614M | 0.7% | $13.61 | — | ADS | 925050106 |
| — | Galmed Pharmaceuticals Ltd | 971,337 | $7.139M | 0.7% | $11.38 | — | SHS | M47238106 |
| — | Dermira Inc | 700,000 | $6.692M | 0.6% | $13.55 | — | Common | 24983L104 |
| — | Kala Pharmaceuticals, Inc. | 1,043,020 | $6.654M | 0.6% | $22.84 | — | Common | 483119103 |
| — | Karuna Therapeutics Inc | 325,000 | $6.507M | 0.6% | $20.02 | — | Common | 48576A100 |
| — | Matinas Biopharma Hldgs Inc | 6,818,181 | $5.84M | 0.5% | $1.09 | — | Common | 576810105 |
| — | Zogenix Inc | 105,000 | $5.017M | 0.5% | $40.05 | — | Common | 98978L204 |
| — | Precision Biosciences Inc | 280,511 | $3.717M | 0.3% | $17.95 | — | Common | 74019P108 |
| ACRS | Aclaris Therapeutics, Inc. | 1,647,214 | $3.607M | 0.3% | $19.11 | -71.5% | Common | 00461U105 |
| GNCAQ | Genocea Biosciences Inc | 626,401 | $2.455M | 0.2% | $5.22 | 0.0% | Common | 372427401 |
| — | DBV Technologies S.A. | 269,995 | $2.219M | 0.2% | $6.42 | — | ADR | 23306J101 |
| — | Agile Therapeutics, Inc. | 1,513,975 | $2.21M | 0.2% | $6.21 | — | Common | 00847L100 |
| — | Sierra Oncology, Inc | 2,438,270 | $1.365M | 0.1% | $1.55 | — | Common | 82640U107 |
| — | Selecta Biosciences Inc | 546,054 | $977K | 0.1% | $19.86 | — | Common | 816212104 |
| — | Akari Therapeutics Plc | 345,850 | $699K | 0.1% | $14.00 | — | ADR | 00972G108 |
| — | BioPharmX Corporation | 317,270 | $189K | 0.0% | $0.60 | — | Common | 09072X309 |
| — | Soleno Therapeutics, Inc. - Warrant | 188,772 | $19,000 | 0.0% | $0.14 | — | Warrant | 834203135 |